Karyopharm grants 1,850 RSUs to two newly hired employees
Karyopharm Therapeutics Inc. announced it granted an aggregate of 1,850 restricted stock units (RSUs) to two newly-hired employees under Nasdaq Listing Rule 5635(c)(4).
NEWTON, Mass., Sept.
1, 2026 // -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 1,850 restricted stock units (RSUs) to two newly-hired employees.
These RSU…